DCB-BIF Trial: Randomized Study of Side Branch Drug-Coated Balloon Angioplasty Following Provisional Stenting

Coronary bifurcations present technical challenges that should be addressed for adequate coronary geometry. The first treatment option for complex coronary bifurcations (according to the DEFINITION study), especially in the left main, is the two stent technique (generally DK-Crush).

Simpler bifurcations, where side-branch length is less than 10 mm, are often treated with provisional stenting, which consists of placing only one stent in the main vessel. Side-branch systematic predilation is not recommended in this technique, to minimize the need for a second stent. However, there could be plaque and carina shift, which would severely compromise the side-branch ostium. 

Treating side-branch ostium with no compliant balloons (NCB) might lead to vessel dissection or occlusion, which would call for a second stent. This area, in the long term, is prone to restenosis. This is why the concept of “leave nothing behind” using drug-coated balloons (DCB) is appealing. 

Gao et al. designed the DCB-BIF, a randomized study to assed the efficacy of DCBs vs NCBs for side-branch treatment following main vessel provisional stenting in true coronary bifurcations. The study included patients from 22 centers (mainly in China) with silent ischemia, stable or unstable angina, or acute MI (AMI). The main requirement was side-branch ostium compromise after provisional stenting, with ≥70% stenosis, and patients were randomized 1:1.

Read also: Discordance between Physiology and Imaging Guided PCI in Intermediate Coronary Lesions: Who to trust?

In the DCB group, predilation was performed with a NCB at 1:1 ratio with reference vessel, considering it adequate if residual stenosis was <50%. Subsequently, a DCB was deployed at nominal pressure for 60 seconds (ratio 0.8-1:1). After DCB angioplasty, kissing balloon inflation (KBI) was performed with two NCBs and re-POT. In cases of type C dissection or TIMI flow compromise, a bailout stent was used.

The primary outcome was major adverse cardiovascular event rate (MACE) at 12 months after procedure, including cardiac death, target vessel MI or clinically driven revascularization. Secondary end points included all-cause mortality, spontaneous and periprocedural AMI, target vessel revascularization and crossover to two-stent technique. 

784 patients treated with provisional stenting were included (pinched side-branch), mean age 65, 76.7% were men and 36.6% presented diabetes. Most patients presented unstable angina (61.1%) or non-ST elevation MI (24.5%). 76.1% had Medina 1,1,1, lesions and the treated vessels were mostly the anterior descending (67.9%) and left main (15.2%). IVUS was used in 22.6% of patients and OCT in 4.7%. Crossover to two-sent technique happened in 3.3% of NCB patients and in 3.8% of DCB patients.

Read also: Edge-to-Edge Repair in Atrial Secondary Tricuspid Regurgitation.

At 12 months, 14.2% of NCB patients and 16.4% of DCB patients required a new angiography (P = 0.41). The primary outcome was seen in 12.5% of NCB patients and 7.2% of DCB patients (HR: 0.56; CI 95%: 0.35-0.88; P = 0.013). The risk of spontaneous AMI was higher among NCB patients (3.6% vs. 1.0%; HR: 0.27; CI 95%: 0.09-0.81; P = 0.029), as was target vessel MI (HR: 0.50; IC 95%: 0.30-0.84; P = 0.009).

There were no differences in secondary outcomes. Of the 18 spontaneous MI, only two were caused by stent thrombosis. 

Conclusions

The DCB-BIF showed that, in a specific population, treating the main vessel with a drug eluting stent followed by a drug coated balloon to the compromised side branch, vs non-compliant balloons, significantly reduced cardiovascular events at one year (HR: 0.56) 

Original Title: Drug-Coated Balloon Angioplasty of the Side Branch During Provisional Stenting. The Multicenter Randomized DCB-BIF Trial.

Reference: Gao X, Tian N, Kan J, Li P, Wang M, Sheiban I, Figini F, Deng J, Chen X, Santoso T, Shin ES, Munawar M, Wen S, Wang Z, Nie S, Li Y, Xu T, Wang B, Ye F, Zhang J, Shou X, Chen SL. Drug-Coated Balloon Angioplasty of the Side Branch During Provisional Stenting: The Multicenter Randomized DCB-BIF Trial. J Am Coll Cardiol. 2025 Jan 7;85(1):1-15. doi: 10.1016/j.jacc.2024.08.067. Epub 2024 Oct 28. PMID: 39480378.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Omar Tupayachi
Dr. Omar Tupayachi
Member of the Editorial Board of solaci.org

More articles by this author

RODIN-CUT: Successive Cutting Balloon Technique in Calcified Lesions

Moderate or severe coronary calcification can be a marker of poor prognosis in coronary artery disease, as it significantly increases the risk of failure...

Acute Coronary Syndrome with Multivessel Disease: Best Revascularization Strategy

The gold standard treatment for acute coronary syndrome (ACS), especially acute myocardial infarction (AMI) is primary angioplasty (PCI). However, 40 to 70% of ACS...

Improved Ejection Fraction in Chronic Total Occlusion?

Chronic total occlusions (CTO) represent a significant challenge in the current clinical practice, seeing as CTO percutaneous coronary intervention (PCI) is complex and involves...

Timing in Complete Revascularization in Acute Coronary Syndrome: BIOVASC 2-Year Followup

The concept of complete revascularization (CR) has been comprehensively studied, leading to diverse approaches and debates on optimal timing.  The BIOVASC trial explored the ideal...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

RODIN-CUT: Successive Cutting Balloon Technique in Calcified Lesions

Moderate or severe coronary calcification can be a marker of poor prognosis in coronary artery disease, as it significantly increases the risk of failure...

Acute Coronary Syndrome with Multivessel Disease: Best Revascularization Strategy

The gold standard treatment for acute coronary syndrome (ACS), especially acute myocardial infarction (AMI) is primary angioplasty (PCI). However, 40 to 70% of ACS...

Improved Ejection Fraction in Chronic Total Occlusion?

Chronic total occlusions (CTO) represent a significant challenge in the current clinical practice, seeing as CTO percutaneous coronary intervention (PCI) is complex and involves...